Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Zhu H, Wang M, Dong Y, Hu H, Zhang Q, Qiao C, et al. Detection of non-criteria autoantibodies in women without apparent causes for pregnancy loss. J Clin Lab Anal. 2019;33(9):e22994.

Magro CM, Halteh P, Olson LC, Kister I, Shapiro L. Linear scleroderma "en coup de sabre" with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy. Orphanet J Rare Dis. 2019;14(1):110.

Yang HS, Edinboro L. Therapeutic Drug Monitoring of Lacosamide by LC-MS/MS. Methods Mol Biol. 2019;1872:67-73.

Nuovo G, Nicol A, de Andrade CV, Magro C. New biomarkers of human papillomavirus infection in epidermodysplasia verruciformis. Ann Diagn Pathol. 2019;40:81-87.

DeSimone RA, Hayden JA, Mazur CA, Vasovic LV, Sachais BS, Zhao Z, et al. Red blood cells donated by smokers: A pilot investigation of recipient transfusion outcomes. Transfusion. 2019;59(8):2537-2543.

Oriakhi M, Ortiz-Diaz E, Olibrice M, Ahluwalia M, Chadburn A, Shostak E. Endobronchial Obstruction by a Solitary Extramedullary Plasmacytoma With Light-chain Amyloidosis. J Bronchology Interv Pulmonol. 2019;26(2):e24-e26.

Siddiqui MT, Schmitt F, Churg A. Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma. J Am Soc Cytopathol. 2019;8(6):352-361.

Tierney JF, Vogle A, Poirier J, Min IM, Finnerty B, Zarnegar R, et al. Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study. Surgery. 2019;165(1):196-201.

Karras P, Riveiro-Falkenbach E, Cañón E, Tejedo C, Calvo TG, Martínez-Herranz R, et al. p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors. Cancer Cell. 2019;35(1):46-63.e10.

Hogan M, Geyer JT, Bussel JB. Response to thrombopoietic agents is related to on-treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia. Am J Hematol. 2019;94(7):E196-E198.